Evidence map›Paper›PMID 31889803›Full record

ArticleSaudi journal of biological sciences2019

The clinical effect of Prednisone in combination with Mycophenolate mofetil on idiopathic thrombocytopenic purpura (ITP) and its influence on the level of peripheral blood T lymphocytes and NK lymphocytes.

Jiangwei Xu, Gangzuo Wang, Sihai Tan, Yirong Ge, Jingzhen Liu, Mei Rao, Yufeng Deng

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Rituximab resistance in ITP and beyond.Frontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jiangwei XuDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Gangzuo WangDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Sihai TanDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Yirong GeDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Jingzhen LiuDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Mei RaoDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
Yufeng DengDepartment of Pediatrics, Department of Western Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi 445000, China.
The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore he curative effect and safety of Prednisone in combination with Mycophenolate in treating ITP and its influence on the level of peripheral blood T lymphocytes and NK lymphocytes.

method93 cases of ITP patients were divided into the observation group and the control group by the Random Number Table method, 48 cases for the observation group, 45 for another. Patients in the control group orally took 0.5 mg/kg Prednisone Acetate tablets daily, two times each in the morning and evening. And the observation group, based on the treatment of the control group, orally took Mycophenolate Mofetil Dispersible tablets twice a day, 1 g each time. According to patients' conditions, 3 to 5 courses were set for treatment with 3 weeks a course. Compared PLT amount and the changing situation of inflammatory factors, CD3

resultAfter treatment, PLT amount in both groups increased, and the increase in the observation group was much higher than that of the control group, the difference had statistical significance (

conclusionThe curative effect of Prednisone in combination with Mycophenolate on ITP patients is better than orally taking Prednisone tablets. Moreover, when it comes to Prednisone in combination with Mycophenolate, both the PLT amount and immunocompetence are improved without much adverse reaction, and the molecules of peripheral blood T lymphocytes and NK lymphocytes can be effectively adjusted to relieve the symptoms. So the method is trustworthy to be popularized for clinical practices.

Indexed as

ITPMycophenolateNK lymphocytePrednisoneT lymphocyte

Identifiers

PMID31889803
PMCPMC6923462
OpenAlexW2972681071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.